JP2013507337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507337A5 JP2013507337A5 JP2012532587A JP2012532587A JP2013507337A5 JP 2013507337 A5 JP2013507337 A5 JP 2013507337A5 JP 2012532587 A JP2012532587 A JP 2012532587A JP 2012532587 A JP2012532587 A JP 2012532587A JP 2013507337 A5 JP2013507337 A5 JP 2013507337A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- component comprises
- glycol
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09012724A EP2308468A1 (en) | 2009-10-08 | 2009-10-08 | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
| EP09012724.2 | 2009-10-08 | ||
| PCT/EP2010/064965 WO2011042485A1 (en) | 2009-10-08 | 2010-10-07 | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013507337A JP2013507337A (ja) | 2013-03-04 |
| JP2013507337A5 true JP2013507337A5 (https=) | 2013-11-07 |
| JP5764792B2 JP5764792B2 (ja) | 2015-08-19 |
Family
ID=41435414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532587A Active JP5764792B2 (ja) | 2009-10-08 | 2010-10-07 | マクロライド免疫抑制剤を含む新規な医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8574562B2 (https=) |
| EP (2) | EP2308468A1 (https=) |
| JP (1) | JP5764792B2 (https=) |
| KR (1) | KR101790257B1 (https=) |
| CN (1) | CN102510752B (https=) |
| AU (1) | AU2010305404B2 (https=) |
| BR (1) | BR112012007332B1 (https=) |
| CA (1) | CA2774720C (https=) |
| ES (1) | ES2552803T3 (https=) |
| IN (1) | IN2012DN01559A (https=) |
| MX (1) | MX2012003800A (https=) |
| WO (1) | WO2011042485A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| WO2012176865A1 (ja) * | 2011-06-23 | 2012-12-27 | 参天製薬株式会社 | ヒアルロン酸またはその塩およびプロピレングリコールを含有する点眼液 |
| WO2014117035A1 (en) | 2013-01-24 | 2014-07-31 | Transderm, Inc. | COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS |
| CN103830178B (zh) * | 2014-03-18 | 2017-01-11 | 深圳劲创生物技术有限公司 | 一种蒜氨酸微乳及其制备方法和应用 |
| RU2737893C2 (ru) * | 2015-08-11 | 2020-12-04 | Айсью Медсинз Б.В. | Пэгилированная липидная наночастица с биоактивным липофильным соединением |
| JP6932180B2 (ja) * | 2016-04-04 | 2021-09-08 | エムシー２・セラピューティクス・リミテッドＭＣ２ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | タクロリムスを含む局所組成物 |
| KR20190016036A (ko) * | 2016-06-03 | 2019-02-15 | 아벡신 에이에스 | 다중불포화 케톤 및 칼시뉴린 억제제를 포함하는 조합 치료요법 |
| CN106074386A (zh) * | 2016-08-31 | 2016-11-09 | 佛山市弘泰药物研发有限公司 | 一种依维莫司自微乳制剂及其制备方法 |
| EP3515422A1 (en) | 2016-09-21 | 2019-07-31 | Avexxin AS | Pharmaceutical composition |
| JP7108631B2 (ja) | 2017-01-06 | 2022-07-28 | パルヴェラ セラピューティクス、インク． | ｍＴＯＲ阻害剤の無水組成物およびその使用方法 |
| WO2019060696A1 (en) | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | OPTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE DISEASE |
| EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
| WO2019233722A1 (en) | 2018-06-08 | 2019-12-12 | Almirall, S.A. | Pharmaceutical composition comprising tacrolimus |
| US11000513B2 (en) | 2018-07-02 | 2021-05-11 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
| CA3124945A1 (en) | 2018-12-27 | 2020-07-02 | Surface Ophthalmics, Inc. | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease |
| CA3164846A1 (en) * | 2020-01-22 | 2021-07-29 | Nayan Desai | Topical compositions comprising a macrolide immunosuppressant |
| TWI769745B (zh) * | 2021-03-19 | 2022-07-01 | 國泰醫療財團法人國泰綜合醫院 | 醫藥組成物與製藥用途 |
| US12310981B2 (en) | 2021-05-10 | 2025-05-27 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
| US12440510B2 (en) | 2021-05-10 | 2025-10-14 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
| BE1030538B1 (nl) | 2022-05-18 | 2023-12-19 | Bogaert Gina Van | Liposomaal preparaat met ingekapselde hormonen, werkwijze voor de productie en gebruik ervan |
| KR102727647B1 (ko) * | 2023-11-28 | 2024-11-08 | 장병모 | 칼시뉴린 억제제를 포함하는 피부질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH26083A (en) * | 1987-11-09 | 1992-02-06 | Sandoz Ltd | 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof |
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| CH686761A5 (de) * | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
| GB2315216B (en) * | 1993-10-05 | 1998-10-14 | Ciba Geigy Ag | Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin |
| ATE299017T1 (de) * | 1994-10-26 | 2005-07-15 | Novartis Pharma Gmbh | Arzneimittel |
| GB9723669D0 (en) * | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
| DE10036871A1 (de) * | 2000-07-28 | 2002-02-14 | Pharmasol Gmbh | Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe |
| IL161588A0 (en) * | 2001-11-01 | 2004-09-27 | Yissum Res Dev Co | Method and composition for dry eye treatment |
| HUP0402318A3 (en) * | 2001-12-14 | 2012-09-28 | Jagotec Ag | Pharmaceutical composition comprising cyclosporin and use thereof |
| AU2005263551B2 (en) * | 2004-07-16 | 2009-04-09 | Novartis Ag | Use of a steroid for enhancement of skin permeability |
| EP1929996B1 (en) * | 2004-11-09 | 2011-02-16 | Novagali Pharma S.A. | Ophthalmic emulsions containing an immunosuppressive agent |
| KR100678829B1 (ko) * | 2004-12-06 | 2007-02-05 | 한미약품 주식회사 | 타크로리무스의 경구용 마이크로에멀젼 조성물 |
| EP1848407A2 (en) * | 2005-02-02 | 2007-10-31 | Mega Lifesciences Pvt. Ltd. | Oral pharmaceutical composition |
| US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| JP4974903B2 (ja) * | 2005-02-09 | 2012-07-11 | 参天製薬株式会社 | 疾患または状態を処置するための液体処方物 |
-
2009
- 2009-10-08 EP EP09012724A patent/EP2308468A1/en not_active Withdrawn
-
2010
- 2010-10-07 KR KR1020127009028A patent/KR101790257B1/ko active Active
- 2010-10-07 WO PCT/EP2010/064965 patent/WO2011042485A1/en not_active Ceased
- 2010-10-07 CN CN201080042067.1A patent/CN102510752B/zh active Active
- 2010-10-07 EP EP10762917.2A patent/EP2485714B1/en active Active
- 2010-10-07 BR BR112012007332-0A patent/BR112012007332B1/pt active IP Right Grant
- 2010-10-07 JP JP2012532587A patent/JP5764792B2/ja active Active
- 2010-10-07 US US13/498,182 patent/US8574562B2/en active Active
- 2010-10-07 ES ES10762917.2T patent/ES2552803T3/es active Active
- 2010-10-07 AU AU2010305404A patent/AU2010305404B2/en active Active
- 2010-10-07 MX MX2012003800A patent/MX2012003800A/es active IP Right Grant
- 2010-10-07 CA CA2774720A patent/CA2774720C/en active Active
-
2012
- 2012-02-21 IN IN1559DEN2012 patent/IN2012DN01559A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507337A5 (https=) | ||
| US11622945B2 (en) | Topical pharmaceutical compositions | |
| US20100063008A1 (en) | Gelatinous elastomer compositions | |
| US9056086B2 (en) | Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof | |
| CA2816203C (en) | Aripiprazole compositions and methods for its transdermal delivery | |
| US8992994B2 (en) | Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis | |
| CN1767826A (zh) | 包括免疫抑制剂的用于治疗皮肤疾病的药物组合物 | |
| JP7502242B2 (ja) | 状態を予防及び治療するための組成物及び方法 | |
| Alamoudi et al. | A comparative dermatokinetic evaluation of thymoquinone-loaded nanoemulsion gel for enhanced wound healing and anti-inflammatory efficacy | |
| US9789123B2 (en) | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis | |
| KR20220008721A (ko) | 카라기난을 포함하는 피부 외용 연고제 조성물 | |
| CA3118698A1 (en) | Teriflunomide topical pharmaceutical compositions | |
| RU2859799C1 (ru) | Средство для лечения воспалительных дерматозов, в том числе осложненных бактериальной и/или грибковой инфекцией | |
| Mittal et al. | Niosomes-Based Pharmacotherapy for the Management of Psoriasis | |
| TR2022020852A2 (tr) | Propoli̇s ve dekspantenol nanoemülsi̇yonlarini i̇çeren hi̇drojel ve organojel formülasyonlari | |
| WO2011114214A2 (en) | Microparticles of epidermal lipids containing polyalcohol for the preparation of cosmetic or pharmaceutical compositions | |
| HK1260924A1 (en) | Topical formulations and uses thereof | |
| HK1260924B (en) | Topical formulations and uses thereof |